First Trust Direct Indexing’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,258
| Closed | -$992K | – | 385 |
|
|
2024
Q3 | $992K | Sell |
24,258
-283
| -1% | -$11.6K | 0.05% | 346 |
|
|
2024
Q2 | $945K | Sell |
24,541
-587
| -2% | -$22.6K | 0.06% | 321 |
|
|
2024
Q1 | $1.08M | Buy |
25,128
+1,078
| +4% | +$46.2K | 0.08% | 280 |
|
|
2023
Q4 | $891K | Buy |
24,050
+10,804
| +82% | +$400K | 0.08% | 293 |
|
|
2023
Q3 | $480K | Buy |
13,246
+387
| +3% | +$14K | 0.05% | 412 |
|
|
2023
Q2 | $458K | Sell |
12,859
-2,709
| -17% | -$96.5K | 0.05% | 435 |
|
|
2023
Q1 | $554K | Buy |
15,568
+5,046
| +48% | +$180K | 0.07% | 368 |
|
|
2022
Q4 | $370K | Buy |
10,522
+2,305
| +28% | +$81K | 0.05% | 456 |
|
|
2022
Q3 | $242K | Sell |
8,217
-1,433
| -15% | -$42.2K | 0.04% | 523 |
|
|
2022
Q2 | $525K | Buy |
9,650
+1,208
| +14% | +$65.7K | 0.07% | 339 |
|
|
2022
Q1 | $460K | Buy |
8,442
+901
| +12% | +$49.1K | 0.06% | 391 |
|
|
2021
Q4 | $416K | Buy |
7,541
+654
| +9% | +$36.1K | 0.05% | 403 |
|
|
2021
Q3 | $329K | Buy |
6,887
+681
| +11% | +$32.5K | 0.05% | 453 |
|
|
2021
Q2 | $309K | Buy |
+6,206
| New | +$309K | 0.05% | 456 |
|